- Home
- HOLO vs CNTX Comparison
HOLO vs CNTX Comparison
Compare HOLO & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOLO | CNTX |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.3M | 47.7M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HOLO | CNTX |
|---|---|---|
| Price | $1.72 | $0.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $6.60 |
| AVG Volume (30 Days) | 303.8K | ★ 2.2M |
| Earning Date | 08-10-2023 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.39 |
| EPS | ★ 1454000.00 | N/A |
| Revenue | ★ $72,512,835.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.00 | ★ N/A |
| Revenue Growth | ★ 28.83 | N/A |
| 52 Week Low | $1.43 | $0.35 |
| 52 Week High | $7.03 | $3.62 |
Technical Indicators
Market Signals| Indicator | HOLO | CNTX |
|---|---|---|
| Relative Strength Index (RSI) | 53.23 | 28.21 |
| Support Level | $1.52 | N/A |
| Resistance Level | $1.88 | $0.70 |
| Average True Range (ATR) | 0.11 | 0.04 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 34.87 | 8.31 |
Price Performance
Historical ComparisonAbout HOLO MicroCloud Hologram Inc.
MicroCloud Hologram Inc provides holographic technology services. Its services include holographic light detection and ranging (LiDAR) solutions, holographic LiDAR point cloud algorithms architecture design, technical holographic imaging solutions, holographic LiDAR sensor chip design, and holographic vehicle intelligent vision technology to service customers that provide holographic driver assistance systems (ADAS). The company also provides holographic digital twin technology services for customers and has built a proprietary holographic digital twin technology resource library. MicroCloud's operating segments are: Holographic technology service, which generates maximum revenue, and Holographic solutions. Its revenues are mainly generated in the People's Republic of China (PRC).
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.